Atlantic Therapeutics | Susan Trent, CEO

Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Susan Trent
Susan Trent
CEO, Atlantic Therapeutics